Jean-Paul R Bosmans

This inventor holds 21 USPTO granted patents, primarily in Pharmaceutical Compounds. Top assignees: Janssen Pharmaceutica Nv, Tanssen Pharmaceutica N.v.. Active years: 1993-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Paul R Bosmans. Retrieved from https://idiyas.com/inventor/jean-paul-r-bosmans

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 54(Granted Patents)

Location History:

Kortrijk-Marke, BE (1993 - 1997)
Edegem, BE (1995 - 1999)
Rijkevorsel, BE (1999 - 2000)

Company Filing History:

20 out of 2,101

Janssen Pharmaceutica Nv

patents

1 out of 1

Tanssen Pharmaceutica N.v.

patent

Years Active: 1993-2000

Loading Chart...

Areas of Expertise:

Dopamine D4 Receptor Antagonist

5HT4 Receptor Antagonists

Enterokinetic Benzamide

Prokinetic Compounds

HIV-Inhibiting Derivatives

Phenyl-Oxo-Alkyl-Benzoate

Dimethylbenzofuran Derivatives

Heterocycle-Substituted Compounds

Pyridine-Substituted Derivatives

Benzenemethanamine Derivatives

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6159982 - 2,4-diaminopyrimidine derivates as dopamine D4 receptor antagonist (2000-12-12),

2. 6096761 - Esters of 3-hydroxy-piperidinemethanol derivatives (2000-08-01),

3. 5990159 - Use of 5HT4 receptor antagonists for overcoming gastrointestinal effects (1999-11-23),

4. 5948794 - Enterokinetic benzamide (1999-09-07),

5. 5872131 - Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives (1999-02-16),

6. 5863923 - Dimethylbenzofuran and dimethylbenzopyran derivatives and their use as (1999-01-26),

7. 5854261 - Prokinetic compounds (1998-12-29),

8. 5854260 - Enterokinetic benzamide (1998-12-29),

9. 5684049 - HIV-inhibiting benzeneacetamide derivatives (1997-11-04),

10. 5674868 - Dimethylbenzofuran and dimethylbenzopyran derivatives and their use as (1997-10-07),

11. 5604230 - Heterocycle-substituted benzenemethanamine derivatives (1997-02-18),

12. 5587387 - Heterocycle-substituted benzenemethanamine derivatives (1996-12-24),

13. 5556886 - HIV-inhibiting benzeneacetamide derivatives (1996-09-17),

14. 5552430 - Heterocycle-substituted benzenemethanamine derivatives (1996-09-03),

15. 5550135 - Heterocycle-substituted benzenemethanamine derivatives (1996-08-27),

Title: The Innovative Contributions of Jean-Paul R Bosmans

Introduction

Jean-Paul R Bosmans, based in Edegem, Belgium, is a notable inventor with a substantial portfolio of innovations, holding 21 patents to his name. His work primarily focuses on pharmaceutical developments that have significant implications in the field of medicine.

Latest Patents

Among his latest patents are two noteworthy inventions: "2,4-diaminopyrimidine derivatives as dopamine D4 receptor antagonist" and "Esters of 3-hydroxy-piperidinemethanol derivatives." These contributions reflect his dedication to advancing therapeutic options for various medical conditions.

Career Highlights

Jean-Paul has had an impressive career at prestigious organizations. He has worked with Janssen Pharmaceutica NV and Tanssen Pharmaceutica NV, companies renowned for their cutting-edge research and development in pharmaceuticals. His work in these environments has greatly shaped his innovative capabilities and offerings.

Collaborations

Collaboration has been a significant aspect of Jean-Paul's career. Notable colleagues such as Georges H Van Daele and Paul A Janssen have worked alongside him, contributing to a synergistic environment that fosters impactful pharmaceutical advancements.

Conclusion

Jean-Paul R Bosmans exemplifies the essence of innovation and collaboration within the pharmaceutical industry. His extensive patent portfolio and collaborations highlight his critical role in shaping medical treatments and advancing healthcare solutions. His work continues to inspire future inventors and researchers in the field.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]